News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,148 Results
Type
Article (28)
Press Release (3120)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Allergies (1)
Alliances (44)
Alzheimer's disease (30)
Approvals (109)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (297)
Breast cancer (9)
Cancer (78)
Career advice (1)
Cervical cancer (1)
Clinical research (655)
Collaboration (4)
Compensation (1)
COVID-19 (4)
Data (90)
Diabetes (1)
Diagnostics (22)
Drug discovery (1)
Drug pricing (1)
Earnings (1451)
Events (341)
FDA (139)
Frontotemporal dementia (1)
Funding (4)
Generative AI (1)
Gene therapy (4)
GLP-1 (8)
Government (9)
Guidances (12)
Healthcare (85)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (161)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (30)
Lymphoma (10)
Manufacturing (1)
MASH (4)
Medical device (56)
Medtech (56)
Mergers & acquisitions (25)
Metabolic disorders (6)
Multiple sclerosis (3)
NASH (1)
Neuroscience (38)
NextGen: Class of 2025 (9)
Non-profit (4)
Obesity (1)
Opinion (1)
Ovarian cancer (1)
Pancreatic cancer (1)
Parkinson's disease (1)
Peanut (1)
People (8)
Phase I (98)
Phase II (198)
Phase III (389)
Pipeline (60)
Policy (1)
Postmarket research (27)
Preclinical (12)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (5)
Regulatory (147)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (1)
Schizophrenia (3)
Startups (3)
Vaccines (5)
Date
Today (2)
Last 7 days (6)
Last 30 days (23)
Last 365 days (415)
2025 (231)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (343)
Australia (13)
California (61)
Canada (22)
China (13)
Connecticut (4)
Delaware (17)
Europe (626)
Florida (10)
Georgia (2)
Illinois (8)
Indiana (17)
Japan (11)
Maryland (13)
Massachusetts (55)
Minnesota (4)
New Jersey (62)
New York (31)
North Carolina (10)
Northern California (41)
Ohio (2)
Pennsylvania (24)
South America (5)
Southern California (14)
Texas (9)
United States (332)
Utah (6)
Washington State (4)
3,148 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novartis twice-yearly* Leqvio® (inclisiran) receives FDA approval for new indication enabling first-line use
July 31, 2025
·
9 min read
Press Releases
Roche’s Lunsumio and Polivy combination significantly prolongs remission for people with relapsed or refractory large B-cell lymphoma
June 23, 2025
·
11 min read
Press Releases
Legacy Healthcare’s Positive Phase 2/3 Trial of Cinainu, First Drug Candidate Targeting Moderate and Severe Alopecia Areata, Published in British Journal of Dermatology
July 23, 2025
·
4 min read
Press Releases
Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence
June 18, 2025
·
11 min read
Press Releases
TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer
July 21, 2025
·
16 min read
Press Releases
Amgen’s TEPEZZA®▼ (teprotumumab) Granted Marketing Authorisation as the First Targeted Treatment Specifically for Adults With Moderate-to-severe Thyroid Eye Disease (TED) in the United Kingdom
May 8, 2025
·
8 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum with 7% growth (CER) in the first half of 2025
July 24, 2025
·
24 min read
Press Releases
AstraZeneca results: H1 and Q2 2025
July 30, 2025
·
10 min read
Press Releases
Taiho Oncology Presents Data at the 2025 American Society of Clinical Oncology Annual Meeting
May 23, 2025
·
6 min read
Press Releases
Blenrep (belantamab mafodotin) combinations approved in Canada for the treatment of relapsed/refractory multiple myeloma
July 23, 2025
·
10 min read
1 of 315
Next
